MARC HOROWITZ to Glioma
This is a "connection" page, showing publications MARC HOROWITZ has written about Glioma.
Connection Strength
0.064
-
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group. J Neurooncol. 2006 Apr; 77(2):193-8.
Score: 0.031
-
Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience. J Neurooncol. 1996 May-Jun; 28(2-3):245-56.
Score: 0.015
-
The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol. 1999 04; 1(2):152-61.
Score: 0.005
-
Phase II evaluation of topotecan for pediatric central nervous system tumors. Cancer. 1996 Aug 01; 78(3):527-31.
Score: 0.004
-
A phase II evaluation of thiotepa in pediatric central nervous system malignancies. Cancer. 1993 Jul 01; 72(1):271-5.
Score: 0.003
-
Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993 Jun 17; 328(24):1725-31.
Score: 0.003
-
Regional blood flow in ethylnitrosourea-induced brain tumors. Ann Neurol. 1983 Aug; 14(2):189-201.
Score: 0.002
-
Regional blood-to-tissue transport in ethylnitrosourea-induced brain tumors. Ann Neurol. 1983 Aug; 14(2):202-15.
Score: 0.002